MANCINI ALEXANDRA DIANE JANET has filed 6 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 240 shares of InMed Pharmaceuticals Inc. ($INM) on July 31, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2024 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Other | S | Common Stock | 240 | $0.18 | 0.0000 | 381,053 | 100.00% | 0.06% |
| May 27, 2024 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 485 | $0.00 | 52,000.0000 | 480,649 | 0.92% | 0.10% |
| Jan. 21, 2024 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 121 | $0.00 | 52,485.0000 | 398,673 | 0.23% | 0.03% |
| Dec. 23, 2023 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 52,606.0000 | 166,410 | 591.64% | 27.04% |
| May 16, 2023 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 485 | $0.00 | 7,606.0000 | 3,328,191 | 5.99% | 0.01% |
| March 8, 2023 | InMed Pharmaceuticals Inc. | $INM | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 61 | $0.00 | 8,091.0000 | 2,300,526 | 0.75% | 0.00% |